/PRNewswire/ Curasight A/S ("Curasight" or "the Company" - TICKER: CURAS) is pleased to announce preclinical data demonstrating the effectiveness of uTREAT®.
Copenhagen, Denmark, 26 May 2023 - Curasight A/S hereby announces that CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the company s Interim Report Q1 2023 at HC. | May 26, 2023
Curasight: Interim report Q1 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
COPENHAGEN, Denmark, May 25, 2023 /PRNewswire/ Curasight A/S hereby publishes the interim report Q1 2023. The interim report is available as an attached file to this release and on the. | May 25, 2023